احمد صبحى عبد الله محمد عماره
أستاذ
Mortality Predictors in Patients with Infective Endocarditis Undergoing Surgery
• 2021
معلومات البحث
المؤلفون
Ahmed Sobhy Emara1
, Tamer Eid Fouda2
, Mostafa Mohammad Abdalraouf Yousof3
, Mohamed Saied
Darwish4
, Abullah Osama Mahfouz*5
الكلمات المفتاحية
Not Available
المجلة العلمية
Not Available
الناشر
Not Available
المجلد
Not Available
العدد
Not Available
الصفحات
Not Available
publication.type
Local
رابط البحث
Not Available
المواد المرفقة
Not Available
الملخص
Background: Infective endocarditis (IE) is considered a series disorder with high in-hospital mortality, so early
detection and therapy can improve outcomes. Diagnosis relies upon consistent history and manifestations like persistent
bacteremia, fungemia or active valvulitis. Surgical treatment in infective endocarditis is considered as a part of
management rather than a consequence of medical treatment failure.
Objectives: To assess the risk factors influencing the early outcome of surgical intervention in patients with IE.
Patients and methods: This prospective cohort study was conducted on sixty patients diagnosed with infective
endocarditis and underwent cardiac surgery. We tested preoperative, intraoperative and postoperative factors that may
act as prospective predictors of mortality.
Results: Rheumatic heart was found to be the most common underlying fundamental issue among most of the cases.
Mitral valve regurgitation was the frequent lesion found (61.7%). The mean EuroScore II in non-survivor group was
25.69 ± 8.13. The hospital mortality was 21.7% (13 patient), while the 6-month mortality was 12.8% (6 patients).
Congestive heart failure, embolization, and periannular extension of infection are the most significant predictors of
hospital mortality and 6 month mortality also.
Conclusion: Surgery for IE keeps on being challenging. EuroScore II was found to have a very good capability to
anticipate mortality in IE surgery. Also favorable outcomes could be acquired with valve repair techniques even in cases
of IE.
detection and therapy can improve outcomes. Diagnosis relies upon consistent history and manifestations like persistent
bacteremia, fungemia or active valvulitis. Surgical treatment in infective endocarditis is considered as a part of
management rather than a consequence of medical treatment failure.
Objectives: To assess the risk factors influencing the early outcome of surgical intervention in patients with IE.
Patients and methods: This prospective cohort study was conducted on sixty patients diagnosed with infective
endocarditis and underwent cardiac surgery. We tested preoperative, intraoperative and postoperative factors that may
act as prospective predictors of mortality.
Results: Rheumatic heart was found to be the most common underlying fundamental issue among most of the cases.
Mitral valve regurgitation was the frequent lesion found (61.7%). The mean EuroScore II in non-survivor group was
25.69 ± 8.13. The hospital mortality was 21.7% (13 patient), while the 6-month mortality was 12.8% (6 patients).
Congestive heart failure, embolization, and periannular extension of infection are the most significant predictors of
hospital mortality and 6 month mortality also.
Conclusion: Surgery for IE keeps on being challenging. EuroScore II was found to have a very good capability to
anticipate mortality in IE surgery. Also favorable outcomes could be acquired with valve repair techniques even in cases
of IE.
